“Luke! Luke! Don’t! It’s a trap!”—spotlight on bias in animal experiments in nuclear oncology
Open Access
- 10 February 2020
- journal article
- letter
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 47 (5) , 1024-1026
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- 18F-Labeled Cyclized α-Melanocyte-Stimulating Hormone Derivatives for Imaging Human Melanoma Xenograft with Positron Emission TomographyScientific Reports, 2019
- Impact of 18F-PSMA-1007 Uptake in Prostate Cancer Using Different Peptide Concentrations: Preclinical PET/CT Study on MiceJournal of Nuclear Medicine, 2019
- Synthesis and preclinical evaluation of novel 18F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with 18F-DCFPyl and 18F-PSMA-1007EJNMMI Research, 2018
- Animal models in translational medicine: Validation and predictionEuropean Journal of Molecular & Clinical Medicine, 2014
- 2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate CancerClinical Cancer Research, 2011
- Can Animal Models of Disease Reliably Inform Human Studies?PLOS Medicine, 2010